ArticleInternational journal of cardiology. Cardiovascular risk and prevention2021

Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?

Jan A Staessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.